Rite Aid Liquid Anesthetic Oral Pain Relief

Description

The drug is formulated as a tablet containing the active ingredient insert active ingredient name here. The tablet exhibits insert physical characteristics, e.g., color, shape, size. Inactive ingredients include list of inactive ingredients.

Uses and Indications

This drug is indicated for the temporary relief of pain associated with canker sores, minor irritation or injury of the mouth and gums, and discomfort resulting from minor dental procedures. It is also effective for alleviating minor irritation of the mouth and gums caused by dentures or orthodontic appliances.

Additionally, this drug is indicated for the temporary relief of sore gums due to teething in children aged 2 years and older.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 2 years and older, the recommended dosage involves applying the product directly to the affected area. The application should remain in place for a minimum of 1 minute before being expectorated. This process may be repeated up to four times daily, or as directed by a dentist or physician.

In the case of teething, the same application method applies, with a maximum frequency of four times per day, unless otherwise instructed by a dentist or physician.

For children under 2 years of age, it is essential to consult a dentist or physician prior to use. Additionally, children under 12 years of age should be supervised during the application of this product to ensure safe and effective use.

Contraindications

There are no specific contraindications listed for this product. However, in the event of accidental ingestion of an amount exceeding that intended for oral anesthetic use, it is imperative to seek medical assistance or contact a Poison Control Center immediately.

Warnings and Precautions

Fever and nasal congestion are not indicative of teething and may suggest an underlying infection. Healthcare professionals should advise patients to seek medical attention if these symptoms persist.

This product should not be used for longer than directed, specifically not exceeding 7 days unless otherwise instructed by a dentist or physician. A history of allergy to local anesthetics, including procaine, butacaine, benzocaine, or other "caine" anesthetics, contraindicates the use of this product.

When utilizing this product, it is imperative to avoid contact with the eyes and to adhere strictly to the recommended dosage.

Patients should be instructed to discontinue use and consult a healthcare provider if sore mouth symptoms do not improve within 7 days, or if any of the following occur: swelling, rash, fever, or if irritation, pain, or redness persists or worsens.

In the event that more than the recommended amount of the oral anesthetic is accidentally ingested, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

General precautions include ensuring that the product is kept out of reach of children to prevent accidental ingestion or misuse.

Side Effects

Patients using this product may experience a range of adverse reactions. Serious adverse reactions include the development of swelling, rash, or fever, which necessitate immediate medical consultation. Additionally, if sore mouth symptoms do not improve within 7 days, patients are advised to stop use and seek medical advice.

Common adverse reactions may include irritation, pain, or redness at the application site, which should be monitored closely. If these symptoms persist or worsen, it is recommended that patients discontinue use and consult a healthcare professional.

Warnings associated with this product indicate that fever and nasal congestion are not typical symptoms of teething and may suggest an underlying infection; in such cases, patients should contact their doctor if these symptoms persist. Furthermore, the product should not be used for more than 7 days unless directed by a dentist or doctor, and individuals with a history of allergy to local anesthetics, such as procaine, butacaine, benzocaine, or other "caine" anesthetics, should avoid its use.

Patients are also cautioned to avoid contact with the eyes and to adhere strictly to the recommended dosage. In the event that more than the recommended amount is accidentally ingested, immediate medical assistance or contact with a Poison Control Center is essential.

Drug Interactions

Patients with a known history of allergy to local anesthetics, including procaine, butacaine, benzocaine, or other "caine" anesthetics, should avoid the use of this medication due to the potential for severe allergic reactions.

No specific drug or laboratory test interactions have been identified in the available data. Therefore, routine monitoring or dosage adjustments related to drug interactions are not necessary.

Packaging & NDC

Below are the non-prescription pack sizes of Rite Aid Liquid Anesthetic Oral Pain Relief (benzocaine). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 2 years and older may use this product for the temporary relief of sore gums due to teething. For children under 2 years of age, it is advised to consult a dentist or doctor prior to use. Additionally, children under 12 years of age should be supervised while using this product. The recommended application is to the affected area not more than 4 times daily, or as directed by a dentist or doctor for teething relief.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The safety of benzocaine during pregnancy has not been established, and its use is contraindicated due to potential risks to the fetus. While specific details regarding these risks are not provided, there may be associated concerns that warrant caution. Pregnant women are advised to consult a healthcare provider prior to using this product to ensure appropriate guidance and consideration of potential fetal outcomes. No specific dosage modifications for pregnant individuals are mentioned in the prescribing information.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there are no statements concerning the potential for excretion in breast milk or any associated risks to breastfed infants during lactation.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of data does not preclude the need for careful evaluation and monitoring based on individual patient circumstances.

Overdosage

In the event of an overdosage of the oral anesthetic, immediate medical assistance is crucial. If a patient accidentally ingests more than the recommended dosage, it is imperative to seek medical help or contact a Poison Control Center without delay.

Healthcare professionals should be aware that symptoms of overdosage may vary, and prompt recognition of these symptoms is essential for effective management. The specific symptoms associated with overdosage have not been detailed; however, vigilance in monitoring the patient for any adverse reactions is advised.

Management of overdosage should include supportive care and symptomatic treatment as necessary. It is recommended that healthcare providers follow established protocols for the management of drug overdosage, which may include monitoring vital signs and providing appropriate interventions based on the patient's clinical presentation.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Postmarketing experience has identified cases of methemoglobinemia associated with the use of benzocaine products, particularly in infants and young children. Additionally, adverse reactions reported in the postmarketing experience include allergic reactions, skin reactions, and other hypersensitivity reactions.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. It is important to emphasize the potential risks associated with misuse.

In the event that a patient accidentally swallows more than the recommended amount intended for oral anesthetic use, they should seek medical assistance immediately or contact a Poison Control Center for guidance. This precaution is crucial to ensure patient safety and appropriate management of any potential overdose.

Storage and Handling

The product is supplied in a tube format, with specific handling and storage requirements to ensure its integrity and efficacy. It should be stored at room temperature, away from direct light exposure. To maintain the quality of the product, it is essential to keep the tube tightly closed when not in use. Additionally, the product should be discarded after opening to prevent any potential degradation or contamination.

Additional Clinical Information

The product is administered orally, with specific instructions for different age groups. For adults and children aged 2 years and older, the application should be made to the affected area, allowing it to remain in place for at least one minute before spitting it out. This can be done up to four times a day or as directed by a dentist or doctor. In the case of teething, the application should not exceed four times daily, also as directed by a healthcare professional. For children under 2 years of age, consultation with a dentist or doctor is advised, and children under 12 years should be supervised during use.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Rite Aid Liquid Anesthetic Oral Pain Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)